Page last updated: 2024-09-03

1-aminoindan and Idiopathic Parkinson Disease

1-aminoindan has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balogh, B; Chai, CL; Chua, YY; Deme, R; Gölöncsér, F; Ho, HK; Huleatt, PB; Khoo, ML; Liew, RS; Magyar, K; Mátyus, P; Sheela, DP; Sperlágh, B; Tan, TW	1

Other Studies

1 other study(ies) available for 1-aminoindan and Idiopathic Parkinson Disease

Article	Year
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease. Journal of medicinal chemistry, 2015, Feb-12, Volume: 58, Issue:3 Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pargyline; Parkinson Disease; PC12 Cells; Propylamines; Rats; Structure-Activity Relationship	2015

Article

Year

Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.

Journal of medicinal chemistry, 2015, Feb-12, Volume: 58, Issue:3

Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pargyline; Parkinson Disease; PC12 Cells; Propylamines; Rats; Structure-Activity Relationship

2015